CareDx (CDNA) Tops Q1 EPS by 40c, provides guidance

CareDx (NASDAQ: CDNA) reported Q1 EPS of $0.34, $0.40 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $117.7 million versus the consensus estimate of $104.12 million.

GUIDANCE:

CareDx sees FY2026 revenue of $447-465 million, versus the consensus of $437.4 million.
The Company now expects full year 2026 adjusted EBITDA to be in the range of $43 million to $57 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August